Compare Boston Scientific Corporation (BSX) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Oxford Lane Capital Corp — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while Oxford Lane Capital Corp trades at $9.3 (market cap $909.61M). The key difference: Boston Scientific Corporation is far larger — about 81.6× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | OXLC | |
|---|---|---|
Market Cap | $74.19B | $909.61M |
Sector | Health | Financials |
52-Week High | $108.14 | $18.75 |
52-Week Low | $42.63 | $8.15 |
Enterprise Value | $86.27B | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
